Related Experiment Video
Updated: Jun 8, 2026

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
An update on the cause and treatment of scleritis
Aleksandra Rachitskaya1, Efrem D Mandelcorn, Thomas A Albini
1Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Purpose Of Review:
To review new clinically relevant data regarding the cause and treatment of scleritis that has been identified over the past 36 months.
Recent Findings:
A recently described T-helper cell population, known as Th-17, has been implicated in scleritis. Large-scale, retrospective reviews of standard corticosteroid-sparing systemic therapies, published in the last few years, have demonstrated only moderate efficacy for any particular immunomodulatory agent, whereas new data have confirmed excellent efficacy and tolerability to subconjunctival corticosteroids.
Summary:
Improved understanding of the immunopathophysiology of scleritis offers hope for future molecule-specific drug design. Data continue to support the use of local steroids as a reasonable therapeutic option for nonnecrotizing, noninfectious anterior scleritis.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Pericarditis III: Medical Management
